{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:57:22Z","timestamp":1790963842731,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,10,27]],"date-time":"2015-10-27T00:00:00Z","timestamp":1445904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,10,27]],"date-time":"2015-10-27T00:00:00Z","timestamp":1445904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Prostate Cancer Prostatic Dis"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1038\/pcan.2015.49","type":"journal-article","created":{"date-parts":[[2015,10,27]],"date-time":"2015-10-27T11:21:38Z","timestamp":1445944898000},"page":"53-56","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Aspirin and NSAID use in association with molecular subtypes of prostate cancer defined by TMPRSS2:ERG fusion status"],"prefix":"10.1038","volume":"19","author":[{"given":"J L","family":"Wright","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Ch\u00e9ry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Holt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D W","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Luedeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A E","family":"Rinckleb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J L","family":"Stanford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,27]]},"reference":[{"key":"BFpcan201549_CR1","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1126\/science.1117679","volume":"310","author":"SA Tomlins","year":"2005","unstructured":"Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 2005; 310: 644\u2013648.","journal-title":"Science"},{"key":"BFpcan201549_CR2","doi-asserted-by":"publisher","first-page":"4706","DOI":"10.1158\/1078-0432.CCR-08-2927","volume":"15","author":"JM Mosquera","year":"2009","unstructured":"Mosquera JM, Mehra R, Regan MM, Perner S, Genega EM, Bueti G et al. Prevalence of TMPRSS2-ERG fusion prostate cancer among men undergoing prostate biopsy in the United States. Clin Cancer Res 2009; 15: 4706\u20134711.","journal-title":"Clin Cancer Res"},{"key":"BFpcan201549_CR3","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/modpathol.3800759","volume":"20","author":"J Lapointe","year":"2007","unstructured":"Lapointe J, Kim YH, Miller MA, Li C, Kaygusuz G, van de Rijn M et al. A variant TMPRSS2 isoform and ERG fusion product in prostate cancer with implications for molecular diagnosis. Mod Pathol 2007; 20: 467\u2013473.","journal-title":"Mod Pathol"},{"key":"BFpcan201549_CR4","doi-asserted-by":"publisher","first-page":"8337","DOI":"10.1158\/0008-5472.CAN-06-1482","volume":"66","author":"S Perner","year":"2006","unstructured":"Perner S, Demichelis F, Beroukhim R, Schmidt FH, Mosquera JM, Setlur S et al. TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer. Cancer Res 2006; 66: 8337\u20138341.","journal-title":"Cancer Res"},{"key":"BFpcan201549_CR5","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1093\/aje\/kwq175","volume":"172","author":"CA Salinas","year":"2010","unstructured":"Salinas CA, Kwon EM, Fitzgerald LM, Feng Z, Nelson PS, Ostrander EA et al. Use of aspirin and other nonsteroidal antiinflammatory medications in relation to prostate cancer risk. Am J Epidemiol 2010; 172: 578\u2013590.","journal-title":"Am J Epidemiol"},{"key":"BFpcan201549_CR6","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/ijc.11250","volume":"106","author":"L Perron","year":"2003","unstructured":"Perron L, Bairati I, Moore L, Meyer F . Dosage, duration and timing of nonsteroidal antiinflammatory drug use and risk of prostate cancer. Int J Cancer. 2003; 106: 409\u2013415.","journal-title":"Int J Cancer."},{"key":"BFpcan201549_CR7","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1158\/1055-9965.649.13.4","volume":"13","author":"LA Garcia Rodriguez","year":"2004","unstructured":"Garcia Rodriguez LA, Gonzalez-Perez A . Inverse association between nonsteroidal anti-inflammatory drugs and prostate cancer. Cancer Epidemiol Biomarkers Prev 2004; 13: 649\u2013653.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BFpcan201549_CR8","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.ejca.2012.09.030","volume":"49","author":"T Veitonm\u00e4ki","year":"2013","unstructured":"Veitonm\u00e4ki T, Tammela TL, Auvinen A, Murtola TJ . Use of aspirin, but not other non-steroidal anti-inflammatory drugs is associated with decreased prostate cancer risk at the population level. Eur J Cancer 2013; 49: 938\u2013945.","journal-title":"Eur J Cancer"},{"key":"BFpcan201549_CR9","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/bjc.2012.227","volume":"107","author":"FM Shebl","year":"2012","unstructured":"Shebl FM, Sakoda LC, Black A, Koshiol J, Andriole GL, Grubb R et al. Aspirin but not ibuprofen use is associated with reduced risk of prostate cancer: a PLCO study. Br J Cancer 2012; 107: 207\u2013214.","journal-title":"Br J Cancer"},{"key":"BFpcan201549_CR10","first-page":"130","volume":"12","author":"K Dasgupta","year":"2006","unstructured":"Dasgupta K, Di Cesar D, Ghosn J, Rajan R, Mahmud S, Rahme E . Association between nonsteroidal anti-inflammatory drugs and prostate cancer occurrence. Cancer J 2006; 12: 130\u2013135.","journal-title":"Cancer J"},{"key":"BFpcan201549_CR11","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.4161\/cbt.7.9.6469","volume":"7","author":"RL Thangapazham","year":"2008","unstructured":"Thangapazham RL, Shaheduzzaman S, Kim KH, Passi N, Tadese A, Vahey M et al. Androgen responsive and refractory prostate cancer cells exhibit distinct curcumin regulated transcriptome. Cancer Biol Ther 2008; 7: 1427\u20131435.","journal-title":"Cancer Biol Ther"},{"key":"BFpcan201549_CR12","doi-asserted-by":"publisher","first-page":"18","DOI":"10.2165\/00003495-198700331-00005","volume":"33","author":"J Vane","year":"1987","unstructured":"Vane J . The evolution of non-steroidal anti-inflammatory drugs and their mechanisms of action. Drugs 1987; 33: 18\u201327.","journal-title":"Drugs"},{"key":"BFpcan201549_CR13","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/bju.12488","volume":"114","author":"DP Nguyen","year":"2014","unstructured":"Nguyen DP, Li J, Yadav SS, Tewari A . Recent insights into NF-\u03baB signaling pathways and the link between inflammation and prostate cancer. BJU Int 2014; 114: 168\u2013176v.","journal-title":"BJU Int"},{"key":"BFpcan201549_CR14","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1023\/A:1006118628183","volume":"17","author":"N Fleshner","year":"1998","unstructured":"Fleshner N, Klotz L . Diet androgens, oxidative stress and prostate cancer susceptibility. Cancer Metastasis Rev 1998-1999; 17: 325\u2013330.","journal-title":"Cancer Metastasis Rev"},{"key":"BFpcan201549_CR15","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/aje\/kwn141","volume":"168","author":"I Agalliu","year":"2008","unstructured":"Agalliu I, Salinas CA, Hansten PD, Ostrander EA, Stanford JL . Statin use and risk of prostate cancer: results from a population-based epidemiologic study. Am J Epidemiol 2008; 168: 250\u2013260.","journal-title":"Am J Epidemiol"},{"key":"BFpcan201549_CR16","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1093\/aje\/kwu344","volume":"181","author":"L Egbers","year":"2015","unstructured":"Egbers L, Luedeke M, Rinckleb A, Kolb S, Wright JL, Maier C et al. Obesity and prostate cancer risk according to tumor TMPRSS2:ERG gene fusion status. Am J Epidemiol 2015; 181: 706\u2013713.","journal-title":"Am J Epidemiol"},{"key":"BFpcan201549_CR17","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nprot.2007.534","volume":"3","author":"B Summersgill","year":"2008","unstructured":"Summersgill B, Clark J, Shipley J . Fluorescence and chromogenic in situ hybridization to detect genetic aberrations in formalin-fixed paraffin embedded material, including tissue microarrays. Nat Protoc 2008; 3: 220\u2013234.","journal-title":"Nat Protoc"},{"key":"BFpcan201549_CR18","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1080\/09553008914550631","volume":"55","author":"KM Prise","year":"1989","unstructured":"Prise KM, Davies S, Michael BD . Cell killing and DNA damage in Chinese hamster V79 cells treated with hydrogen peroxide. Int J Radiat Biol 1989; 55: 583\u2013592.","journal-title":"Int J Radiat Biol"},{"key":"BFpcan201549_CR19","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0960-9822(02)00684-X","volume":"12","author":"ZE Karanjawala","year":"2002","unstructured":"Karanjawala ZE, Murphy N, Hinton DR, Hsieh CL, Lieber MR . Oxygen metabolism causes chromosome breaks and is associated with the neuronal apoptosis observed in DNA double-strand break repair mutants. Cur Biol 2002; 12: 397\u2013402.","journal-title":"Cur Biol"},{"key":"BFpcan201549_CR20","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/ncb1024","volume":"5","author":"S Parrinello","year":"2003","unstructured":"Parrinello S, Samper E, Krtolica A, Goldstein J, Melov S, Campisi J . Oxygen sensitivity severely limits replicative lifespan of murine fibroblasts. Nature Cell Biology. 2003; 5: 741\u2013747.","journal-title":"Nature Cell Biology."},{"key":"BFpcan201549_CR21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nature03688","volume":"436","author":"DC Radisky","year":"2005","unstructured":"Radisky DC, Levy DD, Littlepage LE, Liu H, Nelson CM, Fata JE et al. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 2005; 436: 123\u2013127.","journal-title":"Nature"},{"key":"BFpcan201549_CR22","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1038\/nature08119","volume":"459","author":"P Niethammer","year":"2009","unstructured":"Niethammer P, Grabher C, Look AT, Mitchison T . A tissue-scale gradient of hydrogen peroxide mediates rapid wound detection in zebrafish. Nature 2009; 459: 996\u2013999.","journal-title":"Nature"},{"key":"BFpcan201549_CR23","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/aja.2011.154","volume":"14","author":"Z Wu","year":"2012","unstructured":"Wu Z, Yuan Y, Geng H, Xia S . Influence of immune inflammation on androgen receptor expression in benign prostatic hyperplasia tissue. Asian J Androl 2012; 14: 316\u2013319.","journal-title":"Asian J Androl"},{"key":"BFpcan201549_CR24","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ccr.2013.01.002","volume":"23","author":"J Weischenfeldt","year":"2013","unstructured":"Weischenfeldt J, Simon R, Feuerbach L, Schlangen K, Weichenhan D, Minner S et al. Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer. Cancer Cell 2013; 23: 159\u2013170.","journal-title":"Cancer Cell"},{"key":"BFpcan201549_CR25","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/FJC.0b013e318248acba","volume":"59","author":"B Chen","year":"2012","unstructured":"Chen B, Zhao J, Zhang S, Wu W, Qi R . Aspirin inhibits the production of reactive oxygen species by downregulating Nox4 and inducible nitric oxide synthase in human endothelial cells exposed to oxidized low-density lipoprotein. J Cardiovasc Pharmacol 2012; 59: 405\u2013412.","journal-title":"J Cardiovasc Pharmacol"},{"key":"BFpcan201549_CR26","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.jdiacomp.2004.03.003","volume":"18","author":"E Dragomir","year":"2004","unstructured":"Dragomir E, Manduteanu I, Voinea M, Costache G, Manea A, Simionescu M . Aspirin rectifies calcium homeostasis, decreases reactive oxygen species, and increases NO production in high glucose-exposed human endothelial cells. J Diabetes Complications 2004; 18: 289\u2013299.","journal-title":"J Diabetes Complications"},{"key":"BFpcan201549_CR27","doi-asserted-by":"publisher","first-page":"e16412","DOI":"10.1371\/journal.pone.0016412","volume":"6","author":"SM Mahmud","year":"2011","unstructured":"Mahmud SM, Franco EL, Turner D, Platt RW, Beck P, Skarsgard D et al. Use of non-steroidal anti-inflammatory drugs and prostate cancer risk: a population-based nested case-control study. PLoS One 2011; 6: e16412.","journal-title":"PLoS One"},{"key":"BFpcan201549_CR28","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1002\/ijc.25465","volume":"128","author":"AS Murad","year":"2011","unstructured":"Murad AS, Down L, Davey Smith G, Donovan JL, Athene Lane J, Hamdy FC et al. Associations of aspirin, nonsteroidal anti-inflammatory drug and paracetamol use with PSA-detected prostate cancer: findings from a large, population-based, case-control study (the ProtecT study). Int J Cancer 2011; 128: 1442\u20131448.","journal-title":"Int J Cancer"}],"container-title":["Prostate Cancer and Prostatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/pcan201549.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/pcan201549","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/pcan201549.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T01:46:01Z","timestamp":1718156761000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/pcan201549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,27]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["BFpcan201549"],"URL":"https:\/\/doi.org\/10.1038\/pcan.2015.49","relation":{},"ISSN":["1365-7852","1476-5608"],"issn-type":[{"value":"1365-7852","type":"print"},{"value":"1476-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,27]]},"assertion":[{"value":"8 May 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}